← Browse by Condition
Medical Condition

stomach cancer adenocarcinoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT06532799 Phase 1, Phase 2
Recruiting

TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal Cancer

Enrollment
75 pts
Location
China
Sponsor
Essen Biotech
View Trial →